TipRanks
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market
DRUG
Bright Minds Biosciences
RESEARCH TOOLSreports
Want to see DRUG full AI Analyst Report?

Bright Minds Biosciences (DRUG) Financial Statements

292 Followers

Bright Minds Biosciences Financial Overview

Bright Minds Biosciences's market cap is currently $490.64M. The company's EPS TTM is $-2.76; its P/E ratio is -24.25; Bright Minds Biosciences is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is $-1.12. See an overview of income statement, balance sheet, and cash flow financials.
Sep 25Dec 24Sep 23Sep 22Sep 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating IncomeC$ -13.94MC$ -2.82MC$ -7.39MC$ -14.98MC$ -8.62M
EBITDAC$ -12.15MC$ -2.73MC$ -7.30MC$ -14.96MC$ -27.64K
Net IncomeC$ -12.23MC$ -2.80MC$ -7.37MC$ -14.96MC$ -8.65M
Balance Sheet
Cash & Short-Term InvestmentsC$ 82.91MC$ 5.72MC$ 6.75MC$ 11.63MC$ 19.76M
Total AssetsC$ 84.42MC$ 6.10MC$ 6.88MC$ 12.09MC$ 20.04M
Total DebtC$ 125.78KC$ 118.96KC$ 73.55KC$ 139.91KC$ 0.00
Net DebtC$ -82.78MC$ -5.60MC$ -6.67MC$ -11.49MC$ -19.76M
Total LiabilitiesC$ 2.38MC$ 568.26KC$ 280.86KC$ 1.54MC$ 638.57K
Stockholders' EquityC$ 82.04MC$ 5.54MC$ 6.60MC$ 10.54MC$ 19.40M
Cash Flow
Free Cash FlowC$ -8.69MC$ -1.85MC$ -7.02MC$ -13.59MC$ -7.32M
Operating Cash FlowC$ -8.69MC$ -1.85MC$ -7.02MC$ -13.59MC$ -7.32M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 85.57MC$ 810.57KC$ 2.19MC$ 5.20MC$ 26.06M
Currency in CAD

Bright Minds Biosciences Earnings and Revenue History

Income Statement >

Bright Minds Biosciences Debt to Assets

Balance Sheet >

Bright Minds Biosciences Cash Flow

Cash Flow >

Bright Minds Biosciences Forecast EPS vs Actual EPS

Earnings >